‘Misleading’ Heart Drug Ad; JenaValve Deal Thwarted; SGLT2 Inhibitor to Prevent HF

(MedPage Today) — A TV commercial for bempedoic acid/ezetimibe (Nexlizet) was deemed “false or misleading” by the FDA due to claims the drug is the only nonstatin to lower bad cholesterol and reduce the risk of heart attacks.
After a 6-day court…